美股市場個股詳情

QDEL 窺得兒醫藥

添加自選

42.110
-0.500-1.17%

收盤價 05/13 16:00 (美東)

42.090
-0.020-0.05%

盤後 19:53 (美東)

28.20億總市值-1596市盈率TTM

窺得兒醫藥股票討論區

登錄發表評論

Moomoo AI

03/27 19:19

The market sentiment towards QuidelOrtho Corporation has been negative, reflected in the declining share price. The company's poor performance over the past few years has resulted in a total loss of 5% per year over five years for shareholders.

The Past Three Years for QuidelOrtho (NASDAQ:QDEL) Investors Has Not Been Profitable

Moomoo AI

02/21 04:05

QuidelOrtho's low P/S ratio is a result of its disappointing revenue forecast. Poor revenue performance and below-average growth predictions have dampened investor sentiment and share price.

Revenues Working Against QuidelOrtho Corporation's (NASDAQ:QDEL) Share Price Following 41% Dive

Stock_Drift

02/15 23:07

👀⚡️👀⚡️👀⚡️👀

$窺得兒醫藥(QDEL.US)$
📊⚡️📊

Sturgeons and Stocks

02/15 20:34

$SoundHound AI(SOUN.US)$ $Nano X Imaging(NNOX.US)$ $Digital Brands Group(DBGI.US)$ $窺得兒醫藥(QDEL.US)$

AM Scanning and 10% Gapping 2/15/2024

From YouTube

Moomoo AI

02/14 21:31

J.P. Morgan and William Blair analysts downgraded the stock due to unclear outlook for adj. EPS and core margins. The company's shares are expected to remain under pressure until management improves execution and margins.

QuidelOrtho Crashes as Analysts Downgrade After Q4 Miss

Moomoo AI

2023/12/18 21:33

QuidelOrtho's current P/S ratio is typical for a company with limited growth expectations. Weak revenue growth outlook seems to suppress the stock's P/S ratio with no anticipated improvement to justify a higher P/S ratio.

Investors Don't See Light At End Of QuidelOrtho Corporation's (NASDAQ:QDEL) Tunnel

Moomoo AI

2023/11/10 22:13

Investor confidence hints at potential long-term improvement despite share price decline, but last year's performance and long-term share price weakness spell potential issues, drawing contrarian investors anticipating a turnaround.

Investors Three-year Losses Continue as QuidelOrtho (NASDAQ:QDEL) Dips a Further 7.3% This Week, Earnings Continue to Decline

逍遥投资派

2023/06/03 00:10

$窺得兒醫藥(QDEL.US)$5年來營收持續增長，前4年平均增速57%，2022年發生了一次非常大規模的併購，營收暴增92.3%。
2020年營業利潤隨着營收的暴增而暴增了9.2倍，2021年下滑14%，2022年卻僅僅增長了7%，主要是成本的過快增長和營業費用的暴增引起的。
淨利潤在2020年暴增10倍達到8.1億高點後連續下滑兩年，2022年的下滑主要是受重組和併購費用影響，同時利息費用也有大幅飆升。
2023Q1營收大幅下滑15.6%，營業利潤下滑79%，淨利潤下滑90%，這個規模的下滑預示着收購的餘波還未平息。
目前市盈率9，但是市盈率TTM已經成負數，可以多觀察幾份季報再說。

已翻譯